从长沙走向全球前2%：一所本土医学院的科研，站上世界前沿

Changsha’s research footprint just got a global credential. He Binsheng, president of Changsha Medical University, has been named to the 2026 World’s Top 2% Scientists list, jointly released by Stanford University and Elsevier — an annual ranking that screens nearly 10 million scientists worldwide for citation impact and recent output.

长沙的科研版图，又多了一张国际凭证。长沙医学院校长何彬生入选 2026 年全球前 2% 顶尖科学家年度榜单 —— 该榜单由斯坦福大学与爱思唯尔联合发布，从全球近千万名科学家中按引用影响与年度产出遴选出最顶尖的 2%。

Changsha Medical University, a private medical undergraduate institution in Changsha, has quietly built a distinctive research identity. Three disciplines — clinical medicine, pharmacology & toxicology, and chemistry — have all entered the ESI global top 1%. Under He’s lead, a provincial key lab is turning Pieris japonica, a toxic wild shrub, into green bio-pesticides, while TCM-based feeds and fertilizers have cut antibiotic residues in food by over 65% and heavy metals in soil and water by more than 70%.

长沙医学院是长沙一所民办医学本科院校，走出了特色鲜明的科研道路。临床医学、药理学与毒理学、化学三个学科已全部进入 ESI 全球前 1%。在何彬生带领下，省级重点实验室把一种有毒野生灌木马醉木，转化成绿色生物农药；自主研发的中药饲料与肥料，让食物抗生素残留降低 65% 以上、水土重金属降低 70% 以上。